Healthcare -
Biotechnology - NASDAQ - US
$ 17.06
-3.62 %
$ 1.17 B
Market Cap
-6.16
P/E
Price Target
Average
287.71%
Revenue Forecast
Estimate
28.52%
EBIT
Estimate
--29.86%
Net Income
Estimate
25.66%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arvinas, Inc.
Wall Street analysts predict an average 1-year price target for ARVN of $66.1 , with forecasts ranging from
a
low of
$40 to a high of $87 .
ARVN Lowest Price Target
Wall Street Target
40 USD
134.47%
ARVN Average Price Target
Wall Street Target
66.1 USD
287.71%
ARVN Highest Price Target
Wall Street Target
87 USD
409.96%
REVENUE FORECAST
Revenue Forecast Chart ARVN
EBIT FORECAST
EBIT Forecast Chart ARVN
NET INCOME FORECAST
Net Income Chart ARVN